Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.24
-0.01 (-0.80%)
At close: Aug 15, 2025, 3:59 PM
1.26
1.61%
After-hours: Aug 15, 2025, 05:54 PM EDT

Marker Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
6.59M 3.31M 9.01M 1.24M
Cost of Revenue
13.47M 10.42M 3.68M 3.16M
Gross Profit
-6.88M -7.11M 5.32M -1.92M
Operating Income
-11.12M -14.58M -19.79M -39.48M
Interest Income
437.01K 539.16K 248.06K 5.7K
Pretax Income
-10.68M -14.04M -19.78M -41.88M
Net Income
-10.73M -8.24M -29.93M -41.88M
Selling & General & Admin
4.24M 7.48M 11.34M 12.93M
Research & Development
13.47M 10.42M 11.97M 27.8M
Other Expenses
n/a -10.42M -233K -1.24M
Operating Expenses
17.71M 17.89M 19.79M 39.48M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
17.71M 17.89M 23.3M 40.72M
Income Tax Expense
49.95K 3.67K -15.09K -5.7K
Shares Outstanding (Basic)
8.98M 8.81M 8.35M 7.65M
Shares Outstanding (Diluted)
8.98M 8.81M 8.35M 7.65M
EPS (Basic)
-1.19 -1.93 -3.58 -5.47
EPS (Diluted)
-1.19 -1.93 -3.58 -5.47
EBITDA
-4.53M -11.27M -19.79M -36.31M
EBIT
-4.53M -14.04M -19.79M -39.48M
Depreciation & Amortization
n/a 2.79M 3.68M 3.16M